{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:39:54Z","timestamp":1789540794361,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,6,26]],"date-time":"2017-06-26T00:00:00Z","timestamp":1498435200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00228-017-2287-2","type":"journal-article","created":{"date-parts":[[2017,6,26]],"date-time":"2017-06-26T03:42:48Z","timestamp":1498448568000},"page":"1305-1313","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Adherence of psychopharmacological prescriptions to clinical practice guidelines in patients with eating behavior disorders"],"prefix":"10.1007","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3440-1676","authenticated-orcid":false,"given":"Mar\u00eda del Mar","family":"Ala\u00f1\u00f3n Pardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Ferrit Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Calleja Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Morillas M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,26]]},"reference":[{"key":"2287_CR1","unstructured":"American Psychiatric Association (APA) (2000). Diagnostic and statistical manual of mental disorders. Fourth edition. Text revision: DSM-IV-TR. American Psychiatric Publishing, Arlington."},{"key":"2287_CR2","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/eat.22037","volume":"45","author":"PK Faceli","year":"2012","unstructured":"Faceli PK, Calder GL, Miller KK, Misra M, Lawson EA, Meenaghan E et al (2012) Psychotropic medication use in anorexia nervosa between 1997 and 2009. Int J Eat Disord 45:970\u2013976","journal-title":"Int J Eat Disord"},{"key":"2287_CR3","unstructured":"National Institute for Clinical Excellence (NICE) (2004) Eating disorders. Core interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders. NICE Clinical Guideline 9. First edition. NICE, London. Available at: \nhttp:\/\/www.nice.org.uk\/guidance\/cg9\/resources\/cg9-eating-disorders-full-guideline-2\n\n. [accessed 8 September 2016]"},{"key":"2287_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.psyneuen.2013.09.009","volume":"39","author":"C Gauthier","year":"2014","unstructured":"Gauthier C, Hassler C, Mattar L, Launay J, Callebert J, Steiger H et al (2014) Symptoms of depression and anxiety in anorexia nervosa: links with plasma tryptophan and serotonin metabolism. Psychoneuroendocrinology 39:170\u2013178. doi:\n10.1016\/j.psyneuen.2013.09.009","journal-title":"Psychoneuroendocrinology"},{"key":"2287_CR5","unstructured":"American Psychiatric Association (APA) (2006). Practice guideline for the treatment of patients with eating disorders. Third edition. American Psychiatric Publishing, Arlington. Available at: \nhttp:\/\/psychiatryonline.org\/pb\/assets\/raw\/sitewide\/practice_guidelines\/guidelines\/eatingdisorders.pdf\n\n [accessed 8 september 2016]"},{"key":"2287_CR6","unstructured":"Working Group of the Clinical Practice Guideline for Eating Disorders (2009). Clinical practice guideline for eating disorders. First edition. Quality plan for the National Health System of the Ministry of Health and consumer affairs. Catalan Agency for Health Technology, assessment and research. Spanish Ministry of Health and Consumption, Madrid. Available at: \nhttp:\/\/www.guiasalud.es\/GPC\/GPC_440_Eat_Disorders_compl_en.pdf\n\n [accessed 8 September 2016]"},{"key":"2287_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11920-015-0573-1","volume":"17","author":"SL McElroy","year":"2015","unstructured":"McElroy SL, Guerdjikova AI, Moiri N, Keck PE (2015) Psychopharmacologic treatment of eating disorders: emerging findings. Curr Psychiatry Rep 17:34. doi:\n10.1007\/s11920-015-0573-1","journal-title":"Curr Psychiatry Rep"},{"key":"2287_CR8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1056\/NEJMct0805569","volume":"360","author":"E Attia","year":"2009","unstructured":"Attia E, Walsh BT (2009) Behavioral management for anorexia nervosa. N Engl J Med 360:500\u2013506","journal-title":"N Engl J Med"},{"key":"2287_CR9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1017\/S0033291709005662","volume":"40","author":"TL Root","year":"2010","unstructured":"Root TL, Pisetsky EM, Thornton L, Lichtenstein P, Pedersen NL, Bulik CM (2010) Patterns of co-morbidity of eating disorders and substance use in Swedish females. Psychol Med 40:105\u2013115","journal-title":"Psychol Med"},{"key":"2287_CR10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/10673220216217","volume":"10","author":"MS Bauer","year":"2002","unstructured":"Bauer MS (2002) A review of quantitative studies of adherence to mental health clinical practice guidelines. Harv Rev Psychiatry 10:138\u2013153","journal-title":"Harv Rev Psychiatry"},{"key":"2287_CR11","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1176\/ps.2010.61.12.1255","volume":"61","author":"SL Ettner","year":"2010","unstructured":"Ettner SL, Azocar F, Branstrom RB, Meredith LS, Zhang L, Ong MK (2010) The association of general medical and psychiatric comorbidities with receipt of guideline-concordant care of depression. Psychiatr Serv 61:1255\u20131259","journal-title":"Psychiatr Serv"},{"key":"2287_CR12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1192\/bjp.bp.111.105833","volume":"201","author":"OD Howes","year":"2012","unstructured":"Howes OD, Vergunst F, Gee S, McGuire P, Kapur S, Taylor D (2012) Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation. Br J Psychiatry 201:481\u2013485","journal-title":"Br J Psychiatry"},{"key":"2287_CR13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/NMD.0000000000000093","volume":"202","author":"WR Keller","year":"2014","unstructured":"Keller WR, Fischer BA, McMahon R, Meyer W, Blake M, Buchanan RW (2014) Community adherence to schizophrenia treatment and safety monitoring guidelines. J Nev Ment Dis 202:6\u201312","journal-title":"J Nev Ment Dis"},{"key":"2287_CR14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/intqhc\/12.6.475","volume":"12","author":"RR Owen","year":"2000","unstructured":"Owen RR, Thrush CR, Kirchner JE, Fischer EP, Booth BM (2000) Performance measurement for schizophrenia: adherence to guidelines for antipsychotic dose. Int J Qual Health Care 12:475\u2013482","journal-title":"Int J Qual Health Care"},{"key":"2287_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/1471-244X-13-211","volume":"13","author":"S Patterniti","year":"2013","unstructured":"Patterniti S, Bisserbe JC (2013) Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care service. BMC Psychiatry 13:211. doi:\n10.1186\/1471-244X-13-211","journal-title":"BMC Psychiatry"},{"key":"2287_CR16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/070674370705200311","volume":"52","author":"MJ Sewitch","year":"2007","unstructured":"Sewitch MJ, Blais R, Rahme E, Bexton B, Galarneau S (2007) Receiving guideline-concordant pharmacotherapy for major depression: impact on ambulatory and inpatient health service use. Can J Psychiatr 52:191\u2013200","journal-title":"Can J Psychiatr"},{"key":"2287_CR17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/0163278708328744","volume":"32","author":"PG Stiles","year":"2009","unstructured":"Stiles PG, Boothroyd RA, Dhont K, Beiler PF, Green AE (2009) Adherence to practice guidelines, clinical outcomes and costs among Medicaid enrollees with severe mental illnesses. Eval Health Prof 32:69\u201389","journal-title":"Eval Health Prof"},{"key":"2287_CR18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/oxfordjournals.schbul.a006927","volume":"28","author":"RW Buchanan","year":"2002","unstructured":"Buchanan RW, Kreyenbuchl J, Zito JM, Lehman A (2002) The schizophrenia PORT pharmacological treatment recommendations: conformance and implications for symptoms and functional outcome. Schizophr Bull 28:63\u201373","journal-title":"Schizophr Bull"},{"key":"2287_CR19","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1017\/S0033291705005933","volume":"35","author":"EB Dennehy","year":"2005","unstructured":"Dennehy EB, Suppes T, Rush AJ, Miller AL, Trivedi MH, Crismon ML et al (2005) Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project. Psychol Med 35:1695\u20131705","journal-title":"Psychol Med"},{"key":"2287_CR20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4088\/JCP.v64n0403","volume":"64","author":"T Suppes","year":"2003","unstructured":"Suppes T, Rush AJ, Dennehy EB, Crismon ML, Kashner TM, Toprac MG et al (2003) Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania. J Clin Psychiatry 64:370\u2013382","journal-title":"J Clin Psychiatry"},{"key":"2287_CR21","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/eurheartj\/ehu100","volume":"35","author":"S Fanoe","year":"2014","unstructured":"Fanoe S, Kristensen D, Fink-Jensen A, Jensen HK, Toft E, Nielsen J et al (2014) Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management. Eur Heart J 35:1306\u20131315","journal-title":"Eur Heart J"},{"key":"2287_CR22","unstructured":"Maintenance and Support Services Organization (MSSO). Medical Dictionary for Regulatory Activities (MedDRA) (2013). Gu\u00eda introductoria para la version 16.0. de MedRA. Available at: \nhttp:\/\/www.meddra.org\/sites\/default\/files\/guidance\/file\/intguide_16_0_spanish.pdf\n\n [accessed 26 december 2016]"},{"key":"2287_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-244X-10-8","volume":"10","author":"T Forsner","year":"2010","unstructured":"Forsner T, Hansson J, Brommels M, Wistedt AA, Forsell Y (2010) Implementing clinical guidelines in psychiatry: a qualitative study of perceived facilitators and barriers. BMC Psychiatry 10:8. doi:\n10.1186\/1471-244X-10-8","journal-title":"BMC Psychiatry"},{"key":"2287_CR24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MLR.0b013e3181ca27f6","volume":"48","author":"M Smolders","year":"2010","unstructured":"Smolders M, Laurant M, Verhaak P, Prins M, Van Marwijk H, Penninx B et al (2010) Which physicians and practice characteristics are associated with adherence to evidence-based guidelines for depressive and anxiety disorders? Med Care 48:240\u2013248","journal-title":"Med Care"},{"key":"2287_CR25","doi-asserted-by":"crossref","unstructured":"Balestrieri M, Oriani MG, Simoncini A, Bellantuono C (2013) Psychotropic drug treatment in anorexia nervosa. Search for differences in efficacy\/tolerability between adolescent and mixed-age population Eur Eat Disorders Rev:361\u2013373","DOI":"10.1002\/erv.2240"},{"key":"2287_CR26","first-page":"1281","volume":"165","author":"H Bissada","year":"2008","unstructured":"Bissada H, Tasca GA, Barber AM, Bradwejn J (2008) Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial. Am J Phsiquiatry 165:1281\u20131288","journal-title":"Am J Phsiquiatry"},{"key":"2287_CR27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/eat.20202","volume":"38","author":"C Nickel","year":"2005","unstructured":"Nickel C, Tritt K, Muehlbacher M, Pedrosa Gil F, Mitterlenher FO, Kaplan P et al (2005) Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial. Int J Eat Disord 38:295\u2013300","journal-title":"Int J Eat Disord"},{"key":"2287_CR28","first-page":"464","volume":"52","author":"WH Kaye","year":"1991","unstructured":"Kaye WH, Weltzin TE, Lk H, Bulik CM (1991) An open trial of fluoxetine in patients with anorexia nervosa. J Clin Psychiatry 52:464\u2013471","journal-title":"J Clin Psychiatry"},{"key":"2287_CR29","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1176\/ajp.155.4.548","volume":"155","author":"E Attia","year":"1998","unstructured":"Attia E, Haiman C, Walsh BT, Flater ST (1998) Does fluoxetine augment the inpatient treatment of anorexia nervosa? Am J Psychiatry 155:548\u2013551","journal-title":"Am J Psychiatry"},{"key":"2287_CR30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14306\/renhyd.17.1.4","volume":"17","author":"BE Mart\u00ednez de Morentin-Aldabe","year":"2013","unstructured":"Mart\u00ednez de Morentin-Aldabe BE, Hern\u00e1ndez-Ru\u00edz De Eguilaz M, P\u00e9rez-D\u00edez S, Mart\u00ednez-Hern\u00e1ndez JA (2013) Influencia de la administraci\u00f3n de psicof\u00e1rmacos en el aumento del peso corporal. Rev Esp Nutr Hum Diet 17:17\u201326","journal-title":"Rev Esp Nutr Hum Diet"},{"key":"2287_CR31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5944\/ap.8.1.195","volume":"8","author":"R Calvo Sagardoy","year":"2011","unstructured":"Calvo Sagardoy R (2011) Understanding and overcoming chronic eating behavior disorders. Acci\u00f3n Psicol\u00f3gica 8:35\u201356","journal-title":"Acci\u00f3n Psicol\u00f3gica"},{"key":"2287_CR32","first-page":"173","volume-title":"Grau Touri\u00f1o A, Mart\u00ednez Fern\u00e1ndez J, Perote Alejandre A","author":"FJ Vaz Leal","year":"2012","unstructured":"Vaz Leal FJ (2012) Indicadores de buen y mal pron\u00f3stico. In: Grau Touri\u00f1o A, Mart\u00ednez Fern\u00e1ndez J, Perote Alejandre A. S\u00e1nchez Povedano M. Controversias sobre los trastornos alimentarios. International Marketing Communication, Madrid, pp 173\u2013184"},{"key":"2287_CR33","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00004583-199907000-00012","volume":"38","author":"DB Herzog","year":"1999","unstructured":"Herzog DB, Dorer DJ, Keel PK, Selwyn SE, Ekeblad ER, Flores AT et al (1999) Recovery and relapse in anorexia and bulimia nervosa: a 7.5-year follow-up study. J Am Acad Child Adolesc Psychiatry 38:829\u2013837","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2287_CR34","unstructured":"Rosagro Esc\u00e1mez F (2013) Consumo de psicof\u00e1rmacos, Prevalencia y factores asociados al consumo en una poblaci\u00f3n de gemelos de la regi\u00f3n de Murcia. [Tesis doctoral]. Universidad de Murcia, Murcia. Available at: \nhttps:\/\/digitum.um.es\/xmlui\/bitstream\/10201\/35418\/1\/TesisFcoRosagroEsc%c3%a1mez2013.pdf\n\n accessed 10 December 2016"},{"key":"2287_CR35","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00228-016-2125-y","volume":"72","author":"O Karlstad","year":"2016","unstructured":"Karlstad O, Zo\u00ebga H, Furu K, Bahmanyar S, Martikainen JE, Kieler H et al (2016) Use of drugs for ADHD among adults\u2014a multinational study among 15.8 million adults in the Nordic countries. Eur J Clin Pharmacol 72:1507\u20131514","journal-title":"Eur J Clin Pharmacol"},{"key":"2287_CR36","doi-asserted-by":"publisher","unstructured":"Castelpietra G, Gobbato M, Valent F, De Vido C, Balestrieri M, Icacsson G (2017) Antidepressant use in suicides: a case-control study from the Friuli Venezia Giulia region, Italy, 2005-2014. Eur J Clin Pharmacol. doi:\n10.1007\/s00228-017-2236-0","DOI":"10.1007\/s00228-017-2236-0"},{"key":"2287_CR37","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association (APA)","year":"2013","unstructured":"American Psychiatric Association (APA) (2013) Diagnostic and statistical manual of mental disorders, Fifth edn. American Psychiatric Publishing, Arlington, DSM-V","edition":"Fifth"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-017-2287-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2287-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2287-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T08:10:56Z","timestamp":1505376656000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-017-2287-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,26]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["2287"],"URL":"https:\/\/doi.org\/10.1007\/s00228-017-2287-2","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,26]]}}}